These will probably be ignored rather than patented/monopolized by Big Pharma. A few million treatable cases per year globally, concentrated in low-income countries, is a small market to chase. Medical needs in low-income countries need to be addressed by governments or nonprofits rather than for-profit companies.

EDIT: replaced "100,000 treatable cases" with "a few million treatable cases" per https://pmc.ncbi.nlm.nih.gov/articles/PMC11020954/ referenced by Lol_arco.